Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Opus Genetics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 35 | −1 |
| Shares | 2.83M | 25.0K | 3.10M | +298.4K (+10.7%) |
| Value | $5.69M | $51.0K | $10.9M | +$5.24M (+93.0%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Opus Genetics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 38,012 | $134.2K | 0.00% |
| Legato Capital Management LLC | 16,456 | $58.1K | 0.01% |
| Simplex Trading, LLC | 11,636 | $41.0K | 0.00% |
| Lincoln National Corp | 11,600 | $40.9K | 0.00% |
| Group One Trading, L.P. | 4,862 | $17.2K | 0.00% |
| Bank of America Corp | 46 | $162 | 0.00% |
| ICA Group Wealth Management, LLC | 32 | $113 | 0.00% |
| New England Capital Financial Advisors LLC | 20 | $77 | 0.00% |
| Private Advisor Group, LLC | 20,000 | $71 | 0.00% |
Sold out (10)
Institutions that held Opus Genetics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ameriprise Financial Inc | 30,099 | $60.0K |
| Millennium Management LLC | 24,463 | $49.0K |
| Warberg Asset Management LLC | 21,000 | $42.0K |
| Captrust Financial Advisors | 19,501 | $39.0K |
| Two Sigma Advisers, LP | 18,200 | $37.0K |
| JPMorgan Chase & Co | 15,600 | $31.0K |
| Susquehanna Fundamental Investments, LLC | 15,105 | $30.0K |
| Cornerstone Capital, Inc. | 13,857 | $28.0K |
| Kestra Private Wealth Services, LLC | 10,000 | $20.0K |
| UBS Group AG | 1,700 | $3.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Opus Genetics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eidelman Virant Capital | 25,000 | $51.0K |